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In situ reverse transcriptase polymerase chain reaction (in situ RT-PCR), 
polyclonal chicken antibody and goat anti-chicken antibody conjugated with 
fluorescein isothiocynate (FITC) using confocal laser scanning microscopy 
(CLSM) and negative staining transmission electron microscopy (NSTEM) 
were carried out to detect the NDV-AF2240 in tumor, liver, brain and lung 
during intratumural injection in 4T1 xenotransplant breast tumor in female 
BALB/c mice. A total of 300 female BALB/c mice were divided randomly into 
15 groups (5 non cancerous groups, 10 cancerous groups) consisting 20 
mice per group. The normal control (NC), normal treated with 8, 16, 32 and 
64HA units of NDV-AF2240 respectively named as N/NDV8, N/NDV16, 
N/NDV32 and N/NDV64. The mice in cancerous groups were initially 
inoculated sub-cutaneously with 4T1 cells; co-culture either with NDV-
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AF2240 or/and tamoxifen. Cancerous groups were divided into cancer 
control (CC), cancer treated with only 5 µg/ml tamoxifen citrate (CT), cancer 
treated with 8, 16, 32 and 64HA units of NDV-AF2240 without tamoxifen 
respectively named C/NDV8, C/NDV16, C/NDV32, C/NDV64, cancer treated 
with 8, 16, 32 and 64HA units of NDV-AF2240 with tamoxifen respectively 
named as CT/NDV8, CT/NDV16, CT/NDV32 and CT/NDV64 daily for four 
weeks. The normal mice treated with 8, 16, 32 and 64 HA unit of NDV-
AF2240 did not affect its lifespan. All of the cancerous and non cancerous 
mice survived well and completed the 4-weeks treatment. Only 4 groups of 
mice developed tumor that was CC, CT, CT/CNDV32 and CT/NDV64, 
however these groups survived until end of the 4 weeks of treatment. 
Significant difference (p < 0.05) in mean body weight was found between 
N/NDV16, N/NDV64 and NC. Whereas, for the cancerous groups, mean 
body weight of the mice in CC group were significantly different (p<0.05) to 
compare with C/NDV8, C/NDV32, CT/NDV16, CT/NDV32 and CT/NDV64 
groups. The mean tumour volume and mass of CT/NDV32 and CT/NDV64 
were not significantly different (p> 0.05) to compare with each other and 
cancer control (CC), however, there was significant difference (p <.05) in the 
changes of tumour volume and mass over time. The CC and CT groups had 
a significantly (p<0.05) higher lung weight compared with the other groups. 
The CC group had a significantly (p<0.05) higher of liver weight compared 
with all groups. There was no significant (p>0.05) different in the brain weight 
between CC and all cancerous groups.  To localize HN gene expression of 
NDV-AFF2240 in tissues, in situ RT-PCR was applied on formalin fixed 
paraffin-embedded (FFPE) sections that were positive by negative staining 
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transmission electron microscopy. The HN gene expression was detected in 
all the breast tumor cells. However, it was found mainly in the blood vessels 
of the brain, liver and lung.  The intensity of the HN gene expression in all the 
organs within the same group is significantly similar except the breast tumor 
tissue.  There was no significant different (p>0.05) in HN gene intensity 
between CT/NDV8 and CT/NDV16 groups, however, it was significantly 
different (p<0.05) compared to CT/NDV32 and CT/NDV64 groups. Virus 
dissemination seems to be determined by the infusion dose during 
intratumoral injection.  β actin as internal control was expressed in breast 
cancer tissue, brain, lung and liver. In situ RT-PCR showed similar constant 
strong intensity of β actin gene expression in all mentioned tissues. 
Immunofluoresence and CLSM successfully detected the virus particles in 
tumor and all the organs of the cancerous groups during intratumoral 
injection. In tumor tissue the virus are found in the cells, whereas, in the lung, 
brain and liver are found mainly in the blood vessels. They are mainly found 
at the central vein (C.V.) and sinusoidal capillaries of the liver. This 
phenomenon was similar to results of in situ RT-PCR. Negative staining with 
transmission electron microscopy as a gold standard method was 
successfully used to detect the NDV-AF2240 at breast tumor, lung, liver and 
brain tissues during intratumoral injection in 4T1 xenotransplant breast 
cancer induced in mice. The results illustrated the presence of NDV-AF2240 
in all organs of cancerous groups, but not in the normal groups treated with 
virus. The morphology of Newcastle disease virus was seen pleomorphic, 
spherical and ranging from 60-320 nm. The virion has an envelope and 
prominent surface projections. Occassionally, virions were seen to be rod in 
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shape. Besides observing the whole virus, nucleocapsids which is confined in 
the virion was frequently detected outside the virion and are also seen 
filamentous. The findings of this study showed that NDV-AF2240 suppressed 
the growth of breast cancer and it is disseminated in blood vessels of the 
brain, lung and liver, however, found in the cells of the breast cancer. 
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Kaedah in situ reverse transcriptase polymerase chain reaction (in situ RT-
PCR), antibodi poliklonal ayam dan antibodi kambing anti-ayam FITC 
menggunakan mikroskop pengimbasan laser konfokal dan pewarnaan 
negatif menggunakan mikroskop elektron pancaran telah dijalankan untuk 
mengesan virus NDV-AF2240 di dalam barah payudara, hati, otak dan paru-
paru semasa suntikan intratumoral dalam xenotransplant ketumbuhan 
payudara dalam mencit betina BALB/c. Sejumlah 300 mencit betina BALB/c 
dibahagi secara rambang ke dalam 15 kumpulan (5 kumpulan tiada barah, 
10 kumpulan berbarah) yang mempunyai 20 mencit sekumpulan. Kumpulan 
mencit normal (NC), normal dirawat dengan titer virus 8, 16, 32 dan 64 HA 
unit NDV-AF2240 masing-masing dinamakan N/NDV 8, N/NDV 16, N/NDV 
32 dan N/NDV 64. Mencit dalam kumpulan berbarah disuntik subkutaneus 
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dengan sel kanser payudara mencit 4T1;ko-kultur dengan NDV-AF2240 atau 
bersama tamoxifen. Kumpulan diaruh barah dibahagi kepada barah kawalan 
(CC), barah dirawat dengan 5µg/ml tamoxifen citrate (CT), barah dirawat 
dengan 8, 16, 32, 64 dan 64 HA unit NDV-AF2240 masing-masing ditambah 
dengan tamoxifen; CT/NDV8, CT/NDV16, CT/NDV32 dan CT/NDV64 setiap 
hari selama 4 minggu. Mencit normal yang dirawat dengan 8, 16, 32, 64 HA 
unit NDV-AF2240 tidak menjejaskan jangka hayat. Semua mencit dalam 
kumpulan diaruh barah dan tidak diaruh barah hidup dan menghabiskan 
rawatan 4 minggu tersebut. Hanya 4 kumpulan mencit tersebut ada 
ketumbuhan barah payudara iaitu CC, CT, CT/NDV32 dan CT/NDV64, 
walaubagaimanapun mencit dalam kumpulan ini hidup hingga ke hujung 4 
minggu rawatan. Terdapat perbezaan signifikan (p<0.05) dalam min berat 
badan antara N/NDV16, N/NDV64 dan NC. Antara kumpulan diaruh barah, 
min berat badan mencit kumpulan CC berbeza secara signifikan (p<0.05) 
dibandingkan kepada kumpulan  C/NDV8, C/NDV32, CT/NDV 16, CT/NDV 
32, dan CT/NDV64. Min isipadu dan berat barah CT/NDV32 dan CT/NDV64 
tiada perbezaan signifikan (p>0.05) apabila dibandingkan sesama kumpulan 
ini dan juga kumpulan barah kawalan (CC), walaubagaimanapun, terdapat 
perbezaan signifikan (p<0.05) dalam perubahan isipadu dan berat barah dari 
awal hingga hujung eksperimen. Kumpulan CC dan CT mempunyai berat 
paru-paru yang lebih tinggi secara signifikan (p<0.05) dibandingkan kepada 
kumpulan lain. Kumpulan CC mempunyai berat hati yang tinggi secara 
signifikan (p<0.05) dibandingkan kepada kumpulan lain. Tiada perubahan 
signifikan berat otak (p>0.05) antara kumpulan CC dan kumpulan diaruh 
barah yang lain. In situ RT-PCR dijalankan untuk menentukan 
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pengekspresan gen HN NDV-AF2240 dalam seksyen tisu yang diawet 
formalin dan dibekukan dalam lilin. Gen HN diekspreskan dan ditemui dalam 
semua sel-sel barah payudara, walaubagaimanapun, ia ditemui khususnya 
dalam saluran darah otak, hati dan paru-paru. Keamatan pengekspresan gen 
HN dalam semua organ dalam kumpulan yang sama adalah serupa secara 
signifikan kecuali dalam tisu barah payudara. Tiada perbezaan signifikan 
(p>0.05) dalam keamatan gen HN antara CT/NDV 8 dan CT/NDV 16, 
walaubagaimanapun, terdapat perbezaan signifikan (p<0.05) apabila 
dibandingkan kepada CT/NDV 32 dan CT/NDV 64. Nampaknya penyebaran 
virus ditentukan oleh dos yang diberi semasa suntikan intratumoral. β actin 
sebagai kawalan dalam, diekspres dalam tisu barah payudara, otak, hati dan 
paru-paru. In situ RT-PCR menunjukkan keamatan tinggi ekspresi gen β 
actin yang serupa dalam semua tisu yang disebut sebelum ini. 
Immunofluoresence dan mikroskop pengimbasan laser konfokol telah 
berjaya mengesan partikel-partikel virus di dalam barah dan kesemua organ 
kumpulan diaruh barah semasa suntikan intratumoral. Dalam tisu barah, 
virus ditemui dalam sel-sel, tetapi dalam organ paru-paru, otak dan hati, virus 
banyak ditemui dalam saluran darah. Virus ini khususnya ditemui dalam vena 
sentral dan kapilari sinosodial hati. Fenomena ini adalah sama dengan 
keputusan in situ RT-PCR. Perwarnaan negatif menggunakan mikroskop 
elektron pancaran sebagai kaedah standard emas berjaya digunakan untuk 
mengesan NDV-AF2240 dalam sampel tisu barah, paru-paru, hati dan otak 
semasa suntikan intratumoral. Keputusan menunjukkan kehadiran NDV-
AF2240 di dalam semua organ dalam kumpulan diaruh barah, tetapi bukan 
dalam kumpulan normal dirawat dengan virus. Morfologi virus newcastle 
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disease ditemui dalam bentuk pleomorf, sfera dan berukuran dari 60-320 nm. 
Virionnya ada sampul dan permukaan unjuran yang ketara. Adakalanya, 
virion nampak dalam bentuk rod. Selain daripada memerhatikan virus secara 
keseluruhan, nukleokapsid yang biasanya di dalam virion, kerap ditemui di 
luar virion dan ditemui berfilamentos. Keputusan projek ini menunjukkan 
NDV-AF2240 disebarkan ke otak, paru-paru dan hati semasa suntikan 
intratumoral barah payudara 4T1 dalam mencit betina BALB/c. 
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33 Confocal laser scanning micrographs of NDV-AF2240           115 
in 5μm of FFPE of CT/NDV32 (B) and CT/NDV64 (D) 
in brain tissue 
 
 
34 Confocal laser scanning micrographs of NDV-AF2240           116 
in 5μm of FFPE of CT/NDV32 (B) and CT/NDV64 (D)  
in lung tissue 
 
 
35 Confocal laser scanning micrographs of NDV-AF2240           117 
in 5μm of FFPE of CT/NDV8 (B) and CT/NDV16 (D)  
in lung tissue 
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36 Confocal laser scanning micrographs of NDV-AF2240           118 
in 5μm of FFPE of CT/NDV8 (B) and CT/NDV16 (D) 
in brain tissue 
 
 
37 Confocal laser scanning micrographs of NDV-AF2240           119 
in 5μm of FFPE of CT/NDV8 (B) and CT/NDV16 
(D) in liver tissue 
 
 
38 Confocal laser scanning micrographs of NDV-AF2240           120 
in 5μm of FFPE of C/NDV8 (B) and C/NDV16 (D) 
in lung tissue 
 
 
39 Confocal laser scanning micrographs of NDV-AF2240           121 
in 5μm of FFPE of C/NDV8 (B) and C/NDV16 (D) 
in liver tissue 
 
 
40 Confocal laser scanning micrographs of NDV-AF2240           122 
in 5μm of FFPE of C/NDV8 (B) and C/NDV16 (D) 
in brain tissue 
 
 
41 Confocal laser scanning micrographs of NDV-AF2240           123 
in 5μm of FFPE of C/NDV32 (B) and C/NDV64 (D) 
in liver tissue 
 
 
42 Confocal laser scanning micrographs of NDV-AF2240           124 
in 5μm of FFPE of C/NDV32 (B) and C/NDV64 (D) 
in brain tissue 
  
 
43 Transmission electron micrograph of NDV-AF2240           127 
 isolated from tumor, lung, brain and liver at CT/NDV32  
group 
 
 
 44 Transmission electron micrograph of NDV-AF2240           128 
 isolated from the lung of CT/NDV8 group by NSTEM 
 
 
45 Transmission electron micrograph of NDV-AF2240           128 
 isolated from the liver of CT/NDV64 group by NSTEM 
 
 
46 Transmission electron micrograph of rod shape            129  
NDV-AF2240 
